{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:36:30Z","timestamp":1785861390490,"version":"3.56.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1097\/01.cad.0000217432.71741.da","type":"journal-article","created":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T13:40:43Z","timestamp":1154439643000},"page":"763-769","source":"Crossref","is-referenced-by-count":24,"title":["Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma"],"prefix":"10.1097","volume":"17","author":[{"given":"Jan","family":"Eucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sterz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Krebbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Zavrski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbing","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Heider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Elstner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.1998.16.5.1922","article-title":"Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group","volume":"16","author":"Hiddemann","year":"1998","journal-title":"J Clin Oncol"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2005.03.108","article-title":"Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma","volume":"23","author":"Goy","year":"2005","journal-title":"J Clin Oncol"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1200\/JCO.2005.08.133","article-title":"Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)","volume":"23","author":"Lenz","year":"2005","journal-title":"J Clin Oncol"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00001813-200506000-00002","article-title":"Proteasome: an emerging target for cancer therapy","volume":"23","author":"Zavrski","year":"2005","journal-title":"Anticancer Drugs"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.2005.00546.x","article-title":"Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma","volume":"76","author":"Heider","year":"2006","journal-title":"Eur J Haematol"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.2000.tb06542.x","article-title":"PPAR-\u03b3-mediated regulation of normal and malignant B lineage cells","volume":"905","author":"Padilla","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood-2004-04-1360","article-title":"15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins","volume":"105","author":"Piva","year":"2005","journal-title":"Blood"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00001813-200411000-00004","article-title":"Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma","volume":"15","author":"Eucker","year":"2004","journal-title":"Anticancer Drugs"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.leukres.2003.07.005","article-title":"Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia","volume":"28","author":"Zang","year":"2004","journal-title":"Leuk Res"},{"key":"R11-4-20210203","first-page":"1","article-title":"Peroxisome proliferator-activated receptor \u03b3 and cancers","volume":"9","author":"Koeffler","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1023366117157","article-title":"PPAR gamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro","volume":"79","author":"Liu","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1015670126203","article-title":"Peroxisome proliferator activated receptor gamma (PPAR\u03b3) as a novel target for prostate cancer","volume":"20","author":"Smith","year":"2002","journal-title":"Invest New Drugs"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/2030","article-title":"Differentiation and reversal of malignant changes in colon cancer through PPAR\u03b3","volume":"4","author":"Sarraf","year":"1998","journal-title":"Nat Med"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1046\/j.1471-4159.2002.00899.x","article-title":"Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPAR\u03b3","volume":"81","author":"Zander","year":"2002","journal-title":"J Neurochem"},{"key":"R16-4-20210203","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr Rev"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00062752-200207000-00006","article-title":"Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies","volume":"9","author":"Konopleva","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1016114026769","article-title":"Novel therapeutic approach: ligands for PPAR\u03b3 and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells","volume":"74","author":"Elstner","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/gut.50.4.563","article-title":"A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells","volume":"50","author":"Toyoda","year":"2002","journal-title":"Gut"},{"key":"R20-4-20210203","first-page":"1027","article-title":"Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids","volume":"15","author":"Asou","year":"1999","journal-title":"Int J Oncol"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator activated receptor \u03b3 and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/clim.2001.5181","article-title":"Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-\u03b3 agonists","volume":"103","author":"Padilla","year":"2002","journal-title":"Clin Immunol"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/1097-0142(19880201)61:3<483::AID-CNCR2820610313>3.0.CO;2-L","article-title":"Characterization and comparison of two newly established Epstein\u2013Barr virus-negative lymphoma B-cell lines. Surface markers, growth characteristics, cytogenetics, and transplantability","volume":"61","author":"Abe","year":"1988","journal-title":"Cancer"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/hmg\/ddh195","article-title":"Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes","volume":"13","author":"de Leeuw","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0277-5379(87)90070-8","article-title":"The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viability","volume":"23","author":"Maehara","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R27-4-20210203","first-page":"3344","article-title":"Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo","volume":"58","author":"Kubota","year":"1998","journal-title":"Cancer Res"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.4049\/jimmunol.165.12.6941","article-title":"Peroxisome proliferator activator receptor-\u03b3 agonists and 15-deoxy-\u039412,14-PGJ2 induce apoptosis in normal and malignant B-lineage cells","volume":"165","author":"Padilla","year":"2000","journal-title":"J Immunol"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1158\/1535-7163.1249.3.10","article-title":"Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias","volume":"3","author":"Konopleva","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/B:NEON.0000003728.80052.a8","article-title":"Ligands for PPAR\u03b3 and RAR cause induction of growth inhibition and apoptosis in human glioblastomas","volume":"65","author":"Zang","year":"2003","journal-title":"J Neurooncol"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clim.2004.06.011","article-title":"Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPAR gamma ligands","volume":"113","author":"Ray","year":"2004","journal-title":"Clin Immunol"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1124\/mol.104.007732","article-title":"Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells","volume":"67","author":"Huang","year":"2005","journal-title":"Mol Pharmacol"},{"key":"R33-4-20210203","first-page":"6213","article-title":"Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation","volume":"61","author":"Palakurthi","year":"2001","journal-title":"Cancer Res"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1074-7613(04)00030-5","article-title":"Transcriptional inactivation of STAT3 by PPAR gamma suppresses IL-6-responsive multiple myeloma cells","volume":"20","author":"Wang","year":"2004","journal-title":"Immunity"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.cad.0000217432.71741.da","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:43:26Z","timestamp":1785858206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200608000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.cad.0000217432.71741.da","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}